These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29788009)

  • 1. The Effect of Feeding Behavior on Hypothalamus in Obese Type 2 Diabetic Rats with Glucagon-like Peptide-1 Receptor Agonist Intervention.
    Lu K; Chen X; Yan J; Li X; Huang C; Wan Q; Deng X; Zou Q
    Obes Facts; 2018; 11(3):181-194. PubMed ID: 29788009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Role of Hypothalamic and Plasma Ghrelin in the Feeding Behavior of Obese Type 2 Diabetic Rats with Intraventricular Glucagon-Like Peptide-1 Receptor Agonist Intervention.
    Lu K; Chen X; Deng X; Long J; Yan J
    Obes Facts; 2021; 14(1):10-20. PubMed ID: 33341811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-Like Peptide-1 Receptor Agonist Differentially Affects Brain Activation in Response to Visual Food Cues in Lean and Obese Individuals with Type 2 Diabetes Mellitus.
    Bae JH; Choi HJ; Cho KIK; Kim LK; Kwon JS; Cho YM
    Diabetes Metab J; 2020 Apr; 44(2):248-259. PubMed ID: 31701698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of peripheral administration of exendin-4 on food intake are attenuated by lesions of the central nucleus of amygdala.
    Qiao H; Ren WN; Li HZ; Hou YX
    Brain Res Bull; 2019 May; 148():131-135. PubMed ID: 30862486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice.
    Parthsarathy V; Hogg C; Flatt PR; O'Harte FPM
    Diabetes Obes Metab; 2018 Feb; 20(2):319-327. PubMed ID: 28730728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
    Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
    J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-obesogenic and hypolipidemic effects of a glucagon-like peptide-1 receptor agonist derived from the saliva of the Gila monster.
    Alves PL; Abdalla FMF; Alponti RF; Silveira PF
    Toxicon; 2017 Sep; 135():1-11. PubMed ID: 28579479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans.
    van Bloemendaal L; Veltman DJ; Ten Kulve JS; Groot PF; Ruhé HG; Barkhof F; Sloan JH; Diamant M; Ijzerman RG
    Diabetes Obes Metab; 2015 Sep; 17(9):878-86. PubMed ID: 26094857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.
    Rodriquez de Fonseca F; Navarro M; Alvarez E; Roncero I; Chowen JA; Maestre O; Gómez R; Muñoz RM; Eng J; Blázquez E
    Metabolism; 2000 Jun; 49(6):709-17. PubMed ID: 10877194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
    Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
    Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of glucagon-like peptide-1 receptor agonist is independent of glycaemia normalization in type two diabetic rats.
    Filchenko I; Simanenkova A; Chefu S; Kolpakova M; Vlasov T
    Diab Vasc Dis Res; 2018 Nov; 15(6):567-570. PubMed ID: 30024276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exendin-4 reduces food intake via the PI3K/AKT signaling pathway in the hypothalamus.
    Yang Y; Choi PP; Smith WW; Xu W; Ma D; Cordner ZA; Liang NC; Moran TH
    Sci Rep; 2017 Jul; 7(1):6936. PubMed ID: 28761132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality.
    Anderberg RH; Richard JE; Hansson C; Nissbrandt H; Bergquist F; Skibicka KP
    Psychoneuroendocrinology; 2016 Mar; 65():54-66. PubMed ID: 26724568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones.
    Bing C; King P; Pickavance L; Brown M; Ziegler D; Kaan E; Williams G
    Br J Pharmacol; 1999 May; 127(1):35-42. PubMed ID: 10369453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
    Holst JJ
    Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese Mice.
    Iwasaki S; Hamada T; Chisaki I; Andou T; Sano N; Furuta A; Amano N
    J Pharmacol Exp Ther; 2017 Sep; 362(3):441-449. PubMed ID: 28698254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Effects and Mechanism of L-Citrulline on Anti-obesity by Appetite Suppression in Obese/Diabetic KK-Ay Mice and High-Fat Diet Fed SD Rats.
    Kudo M; Yoshitomi H; Momoo M; Suguro S; Yamagishi Y; Gao M
    Biol Pharm Bull; 2017; 40(4):524-530. PubMed ID: 28381807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exenatide upregulates gene expression of glucagon-like peptide-1 receptor and nerve growth factor in streptozotocin/nicotinamide-induced diabetic mice.
    Gumuslu E; Cine N; Ertan M; Mutlu O; Komsuoglu Celikyurt I; Ulak G
    Fundam Clin Pharmacol; 2018 Apr; 32(2):174-180. PubMed ID: 29091313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide, leptin and their combined effects on feeding: additive intake reduction through common intracellular signalling mechanisms.
    Kanoski SE; Ong ZY; Fortin SM; Schlessinger ES; Grill HJ
    Diabetes Obes Metab; 2015 Mar; 17(3):285-93. PubMed ID: 25475828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding-associated neuropeptides in hypothalamic neurons in vivo and in vitro.
    Dalvi PS; Nazarians-Armavil A; Purser MJ; Belsham DD
    Endocrinology; 2012 May; 153(5):2208-22. PubMed ID: 22334721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.